Skip to main content

A Microfluidic-Free Droplet Technology for Rapid and Quantitative Airborne Pathogen Monitoring

NIAID - National Institute of Allergy and Infectious Diseases

open
OpenLast verified: 2026-06-19

About This Grant

ABSTRACT Pathogen transmission via indirect routes such as fomite, waterborne, and airborne transmission are hallmarks of both endemic and pandemic spread. Viruses such as Influenza, SARS-CoV-2, and measles are notable examples, in addition to deadly microbes such as Bordetella pertussis, Mycobacterium tuberculosis, and Coccidioides species. However, the rapid detection and analysis of airstreams as part of biosurveillance, public health monitoring, or epidemiological research remains challenging. Current state-of-the-art methods rely on bulky apparatuses for both the collection and detection of airborne agents; most of these methods are ill suited to rapid response point-of-testing within medical facilities, workplace locals, or public spaces. Further, these technologies are based on bulk Polymerase Chain Reaction (PCR) and Loop-mediated isothermal amplification (LAMP) methods that have limited quantitative accuracy. Thus, more portable and accurate platforms are needed to address the types of rapid response and ubiquitous monitoring that is required to minimize outbreaks in the 21st century. Towards this objective, this grant will address the need for an improved method of airborne pathogen detection through the development of the digital droplet Aerosol Capture & Quantification (ddACQ) system. The ddACQ system consists of two novel technologies, a filter particle array and a droplet buoyancy counter. The filter particle array allows for the capture of airborne pathogens or biological agents and generation of microfluidic droplets when mixed with an oil and water reagent solution. A phone-powered heat block then drives a one-step isothermal digital droplet reaction. Digital techniques have several key advantages over classical quantitative PCR and LAMP techniques, namely single molecule detection and direct quantification without a standard curve. Finally, the droplet buoyancy counter allows for smartphone based read out of the reaction immediately at the testing site in under an hour. Together, the innovations within and implementation of the ddACQ system represents a novel application of microfluidic principles and an enabling technology for both pathogen transmission research and public health monitoring applications.

Grant Summary

A Microfluidic-Free Droplet Technology for Rapid and Quantitative Airborne Pathogen Monitoring is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $451K for university, nonprofit, healthcare org. Applications are due 2028-03-31 (open). Check eligibility and apply with FindGrants.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $451K

Deadline

2028-03-31

Complexity
Medium
  1. 1Confirm your organization is eligible for A Microfluidic-Free Droplet Technology for Rapid and Quantitative Airborne Pathogen Monitoring from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

A Microfluidic-Free Droplet Technology for Rapid and Quantitative Airborne Pathogen Monitoring: Frequently Asked Questions

Who is eligible for the A Microfluidic-Free Droplet Technology for Rapid and Quantitative Airborne Pathogen Monitoring?

A Microfluidic-Free Droplet Technology for Rapid and Quantitative Airborne Pathogen Monitoring is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the A Microfluidic-Free Droplet Technology for Rapid and Quantitative Airborne Pathogen Monitoring provide?

A Microfluidic-Free Droplet Technology for Rapid and Quantitative Airborne Pathogen Monitoring provides up to $451K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the A Microfluidic-Free Droplet Technology for Rapid and Quantitative Airborne Pathogen Monitoring deadline?

Applications for A Microfluidic-Free Droplet Technology for Rapid and Quantitative Airborne Pathogen Monitoring are due 2028-03-31 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the A Microfluidic-Free Droplet Technology for Rapid and Quantitative Airborne Pathogen Monitoring?

To apply for A Microfluidic-Free Droplet Technology for Rapid and Quantitative Airborne Pathogen Monitoring, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.

Browse More Grants